Ledger.Open graph →

SEC Form D · Amendment · filed March 17, 2016

Potenza Therapeutics, Inc

Offering

$38.0M

Sold

$30.0M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

Cambridge, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

David Greenwald · New York, NYExec Matthew J. Arciuolo · Wilton, CTDirector Kyle Sale · Boise, IDDirector Luke Evnin · Cambridge, MADirector David Cordo · Cambridge, MAExec David Cordo · Cambridge, MAExec Arnold Oronsky · Cambridge, MADirector Reid Leonard · Cambridge, MAExec Cynthia Seidel-Dugan · Cambridge, MAExec Pete Hartigan · San Francisco, CAExec · Director David R. Mchale · Wilton, CTDirector Drew Eldred · Boise, IDExec · Director Sakae Asanuma · Cambridge, MADirector Marc Fussteig · New York, NYDirector Howard S. Morgan · New York, NYDirector Mitchell Vogel · New York, NYExec Micah Johnson · Boise, IDExec David S. Rose · New York, NYExec Arthur Dzaghgouni · Grand Cayman, Cayman IslandsExec · Director Daniel Hicklin · Cambridge, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗